ELANCO ANIMAL HEALTH RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHMon, 06 Apr 2026 03:56:49 +0200https://images.finanzen.net/images/finanzen_net_neu.gifELANCO ANIMAL HEALTH RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netElanco Animal Health mit Zahlen zum abgelaufenen QuartalThu, 26 Feb 2026 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/elanco-animal-health-mit-zahlen-zum-abgelaufenen-quartal-15517919Elanco Animal Health lud am 24.02.2026 zur Finanzkonferenz und hat dort die Zahlen zum am 31.12.2025 abgelaufenen Jahresviertel präsentiert.Das EPS wurde auf einen Verlust von 0,56 USD je Aktie beziffert. ...

]]>https://www.finanzen.net/nachricht/aktien/elanco-animal-health-mit-zahlen-zum-abgelaufenen-quartal-15517919Ausblick: Elanco Animal Health informiert über die jüngsten QuartalsergebnisseMon, 23 Feb 2026 07:01:06 +0100https://www.finanzen.net/nachricht/aktien/ausblick-elanco-animal-health-informiert-ueber-die-juengsten-quartalsergebnisse-15508783Elanco Animal Health präsentiert am 24.02.2026 die Bilanzzahlen zum am 31.12.2025 beendeten Jahresviertel.Die Schätzungen von 15 Analysten belaufen sich im Durchschnitt auf 0,113 USD je Aktie. Im Vorjahresquartal ...

]]>https://www.finanzen.net/nachricht/aktien/ausblick-elanco-animal-health-informiert-ueber-die-juengsten-quartalsergebnisse-15508783Erste Schätzungen: Elanco Animal Health legt Zahlen zum jüngsten Quartal vorMon, 09 Feb 2026 06:21:35 +0100https://www.finanzen.net/nachricht/aktien/erste-schaetzungen-elanco-animal-health-legt-zahlen-zum-juengsten-quartal-vor-15472536Elanco Animal Health wird voraussichtlich am 24.02.2026 das Zahlenwerk zum am 31.12.2025 abgelaufenen Jahresviertel vorstellen.Die Prognosen von 15 Analysten für das im vergangenen Jahresviertel erwirtschaftete ...

]]>https://www.finanzen.net/nachricht/aktien/erste-schaetzungen-elanco-animal-health-legt-zahlen-zum-juengsten-quartal-vor-15472536Elanco to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceTue, 06 Jan 2026 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/elanco-to-participate-in-the-44th-annual-j-p-morgan-healthcare-conference-15395197

INDIANAPOLIS, Jan. 6, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will participate ...

]]>https://www.finanzen.net/nachricht/aktien/elanco-to-participate-in-the-44th-annual-j-p-morgan-healthcare-conference-15395197Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic DermatitisWed, 31 Dec 2025 20:00:00 +0100https://www.finanzen.net/nachricht/aktien/elanco-receives-usda-approval-for-befrena-tirnovetmab-a-new-anti-il31-monoclonal-antibody-injection-targeting-canine-allergic-and-atopic-dermatitis-15387351
  • Elanco's second dermatology product approval in less than 18 months in the estimated $1.3 billion U.S. canine dermatology market
  • Befrena has been shown to be effective ...

    ]]>https://www.finanzen.net/nachricht/aktien/elanco-receives-usda-approval-for-befrena-tirnovetmab-a-new-anti-il31-monoclonal-antibody-injection-targeting-canine-allergic-and-atopic-dermatitis-15387351Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in DogsThu, 18 Dec 2025 14:43:00 +0100https://www.finanzen.net/nachricht/aktien/elanco-s-credelio-quattro-ca1-lotilaner-moxidectin-praziquantel-and-pyrantel-chewable-tablets-receives-first-fda-conditional-approval-for-treatment-of-new-world-screwworm-in-dogs-15368233

    Conditional Approval Marks Elanco's Third New World Screwworm Treatment Option for Companion Animals, Providing Multiple Treatment Solutions Prior to Fly Being Detected in the U.S.

      ]]>https://www.finanzen.net/nachricht/aktien/elanco-s-credelio-quattro-ca1-lotilaner-moxidectin-praziquantel-and-pyrantel-chewable-tablets-receives-first-fda-conditional-approval-for-treatment-of-new-world-screwworm-in-dogs-15368233Elanco Investor Day Defines New Era as Sustainable Growth CompanyTue, 09 Dec 2025 13:40:00 +0100https://www.finanzen.net/nachricht/aktien/elanco-investor-day-defines-new-era-as-sustainable-growth-company-15345558
      • Details three-year outlook with annual mid-single digit top-line organic constant currency growth driven by a consistent flow of high-impact innovation, high-single digit adjusted EBITDA growth ...

        ]]>https://www.finanzen.net/nachricht/aktien/elanco-investor-day-defines-new-era-as-sustainable-growth-company-15345558Elanco's Credelio™ CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in CatsFri, 21 Nov 2025 19:35:00 +0100https://www.finanzen.net/nachricht/aktien/elanco-s-credelio-cat-lotilaner-receives-first-fda-emergency-use-authorization-eua-for-treatment-of-new-world-screwworm-nws-in-cats-15305351

        EUA to Treat Cats for NWS Issued Prior to Fly Being Detected in the U.S.; Action Prepares Veterinarians and Pet Owners with Treatment Options

        • First ...

          ]]>https://www.finanzen.net/nachricht/aktien/elanco-s-credelio-cat-lotilaner-receives-first-fda-emergency-use-authorization-eua-for-treatment-of-new-world-screwworm-nws-in-cats-15305351Elanco to Participate in the Upcoming Investor ConferencesThu, 20 Nov 2025 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/elanco-to-participate-in-the-upcoming-investor-conferences-15295350

          INDIANAPOLIS, Nov. 20, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced ...

          ]]>          https://www.finanzen.net/nachricht/aktien/elanco-to-participate-in-the-upcoming-investor-conferences-15295350          Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human HealthThu, 13 Nov 2025 14:00:00 +0100https://www.finanzen.net/nachricht/aktien/alloy-partners-launches-onehealth-studio-to-create-startups-at-the-convergence-of-animal-plant-and-human-health-15271881

          Alloy Partners, Elanco and other corporate partners join forces to develop new venture studio

          INDIANAPOLIS, ...

          ]]>          https://www.finanzen.net/nachricht/aktien/alloy-partners-launches-onehealth-studio-to-create-startups-at-the-convergence-of-animal-plant-and-human-health-15271881